Novo Nordisk's pricing techniques during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of value gouging, pointing out the stark contrast involving U.S. charges and people in Europe and copyright.This led Novo Nordisk to conduct more study into greater dosages of semaglutide especially for wei